Ligand Pharmaceuticals Inc Tr Beta Contingent Value Rt

0.140000.00Vol 4001Y Perf -37.78%
Nov 18th, 2021 12:43
BID0.0000 ASK0.0000
Open0.1400 Previous Close0.1400
Pre-Market- After-Market-
 - -%  - -
Target Price
- 
Analyst Rating
— — 0.00
Potential %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
12.50 
Earnings Rating
Market Cap- 
Earnings Date
-
Alpha0.08 Standard Deviation0.38
Beta-0.38 

Today's Price Range

0.14000.1400

52W Range

0.11000.3500

5 Year PE Ratio Range

0.00000.0000

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Buy
Performance
1 Week
0.00%
1 Month
-6.67%
3 Months
27.27%
6 Months
-17.65%
1 Year
-37.78%
3 Years
64.71%
5 Years
582.93%
10 Years
0.00%

TickerPriceChg.Chg.%
LGNZZ0.14000.00000.00
AAPL156.81-5.1300-3.17
GOOG2 856.12-78.2300-2.67
MSFT329.68-8.2300-2.44
XOM61.25-2.2300-3.51
WFC48.43-2.8800-5.61
JNJ159.20-1.0400-0.65
FB333.12-7.9400-2.33
GE97.84-4.3900-4.29
JPM161.93-5.0300-3.01
Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume400
Shares Outstanding0
Shares Float20.96M
Trades Count1
Dollar Volume65
Avg. Volume4.79K
Avg. Weekly Volume2.16K
Avg. Monthly Volume5.68K
Avg. Quarterly Volume3.23K
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating-
0.00
-
0.00
-
0.00

Ligand Pharmaceuticals Inc Tr Beta Contingent Value Rt

Metabasis Therapeutics Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of novel drugs by applying its proprietary technologies, scientific expertise and unique capabilities for targeting the liver and liver pathways. The company's products include: Promacta; Kyprolis.

CEO: John L. Higgins

Telephone: +1 858 587-2770

Address: 9390 Towne Centre Dr. Bldg 300, San Diego 92121, CA, USA

Number of employees: 0

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

29%71%

Bearish Bullish

50%50%

News